RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
The invention is directed to 11.beta.-aryl-17,17-spirothiolanesubstituted steroid compounds of formula (I) exhibiting binding tothe progestin receptor. ##STR1## Also disclosed are methods ofusing and process of making the compounds.